UPDATE: Agile Initiates Phase 3 SECURE Study for Twirla By: Benzinga via Benzinga September 16, 2014 at 08:00 AM EDT Agile Therapeutics, Inc., (Nasdaq: AGRX) a women's health specialty pharmaceutical company focused on the development and ... Read More >> Related Stocks: Agile Therapeutics Inc